Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Coya Therapeutics (COYA) Depreciation & Amortization - Total (2023 - 2025)

Historic Depreciation & Amortization - Total for Coya Therapeutics (COYA) over the last 3 years, with Q3 2025 value amounting to $6840.0.

  • Coya Therapeutics' Depreciation & Amortization - Total fell 1.46% to $6840.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $27360.0, marking a year-over-year change of 0.37%. This contributed to the annual value of $27361.0 for FY2024, which is 0.0% changed from last year.
  • Coya Therapeutics' Depreciation & Amortization - Total amounted to $6840.0 in Q3 2025, which was down 1.46% from $6840.0 recorded in Q2 2025.
  • In the past 5 years, Coya Therapeutics' Depreciation & Amortization - Total ranged from a high of $6841.0 in Q3 2023 and a low of $6840.0 during Q1 2023
  • Its 3-year average for Depreciation & Amortization - Total is $6840.2, with a median of $6840.0 in 2023.
  • As far as peak fluctuations go, Coya Therapeutics' Depreciation & Amortization - Total changed by 0.0% in 2024, and later fell by 1.46% in 2025.
  • Over the past 3 years, Coya Therapeutics' Depreciation & Amortization - Total (Quarter) stood at $6840.0 in 2023, then changed by 0.0% to $6840.0 in 2024, then changed by 0.0% to $6840.0 in 2025.
  • Its Depreciation & Amortization - Total was $6840.0 in Q3 2025, compared to $6840.0 in Q2 2025 and $6840.0 in Q1 2025.